Homeopathic treatment of common cold in childre

Phase 2

Conditions: Health Condition 1: J069- Acute upper respiratory infection,unspecified

Registration Number: CTRI/2021/12/038881

Lead Sponsor: D N De Homoeopathic Medical College Hospital

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Open to Recruitment

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1. Clinical signs and symptoms of an upper respiratory tract infections with a duration of greater than or equal to 24 hours with or without fever greater than or equal to 37.5 degree Celsius.

2. At least 1 of 3 types of upper respiratory tract infections symptoms Ã¢â?¬â?? nasal (plugged nose, runny nose, sneezing), pharyngeal (scratchy throat, sore throat, pharyngeal hyperemia),

and cough (ordinary cough without suspicion of acute lower respiratory tract disease).

3. At least 1 of 5 general symptoms Ã¢â?¬â?? feeling tired, weakness, body ache, irritable or whiney, or less active.

4. Literate guardians or attendants capable of understanding and filling the questionnaire and providing written informed consent.

Exclusion Criteria

1. Severe or complicated course of upper respiratory tract infections.

2. Signs of acute lower respiratory tract infections.

3. COVID-19 positive cases.

4. Current symptoms mainly induced by other acute ear, nose, throat diseases.

5. Daily use of antibiotics, steroids and cytotoxic agents.

6. Immune-compromised state.

8. Already undergoing homeopathic or other modes of treatment for upper respiratory tract infections.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of patients in each group showing complete disappearance of the symptoms of upper respiratory tract infection.Timepoint: Baseline and after 4, 8 and 15 days

Secondary Outcome Measures

Name	Time	Method
pper respiratory tract infection symptom severity scale (URI-SSS)Timepoint: Baseline and after 4, 8 and 15 days;Wisconsin Upper Respiratory Symptom Survey (WURSS-21)Timepoint: Baseline and after 4, 8 and 15 days